Stockscreener 앱 받기
88.23
1.26%
-1.13
Vaneck Pharmaceutical Etf 주식(PPH)의 최신 뉴스
Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies - Benzinga
PPH: Global Pharma Stocks Continue To Face Headwinds, Tariffs Front And Center (PPH) - Seeking Alpha
Janney Montgomery Scott LLC Cuts Stake in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
PPH's Dividend Surge: A Healthcare Income Play in Volatile Markets - AInvest
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? - sharewise.com
Global pharma stocks down as Trump renews tariff threat - MSN
Millennium Management LLC Lowers Position in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Trump says pharma tariffs are coming in the “not-too-distant-future” - MSN
Ameriprise Financial Inc. Sells 3,806 Shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Ameriprise Financial Inc. Decreases Stock Position in SPDR S&P Bank ETF (NYSEARCA:KBE) - Defense World
Innovator Growth-100 Power Buffer ETF – September (NYSEARCA:NSEP) Holdings Lifted by Jane Street Group LLC - Defense World
Invesco S&P 500 Pure Growth ETF (NYSEARCA:RPG) Stake Boosted by Ameriprise Financial Inc. - Defense World
D. E. Shaw & Co. Inc. Trims Stake in Vanguard S&P 500 Value ETF (NYSEARCA:VOOV) - Defense World
D. E. Shaw & Co. Inc. Has $363,000 Stake in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
VanEck Pharmaceutical ETF (NASDAQ:PPH) Shares Sold by D. E. Shaw & Co. Inc. - Defense World
D. E. Shaw & Co. Inc. Decreases Holdings in SPDR S&P 600 Small Cap Growth ETF (NYSEARCA:SLYG) - Defense World
VanEck Pharmaceutical ETF (NASDAQ:PPH) Stake Raised by Bank of America Corp DE - Defense World
Bank of America Corp DE Purchases 1,732 Shares of VanEck Retail ETF (NASDAQ:RTH) - Defense World
Should You Invest in the VanEck Pharmaceutical ETF (PPH)? - MSN
Gilead and Vertex Pharma named among biotech’s tariff safe havens - MSN
Here's How Trump Plans To Tackle Drug Prices, And Why It Might Not Work - Inkl
VanEck Pharmaceutical ETF (NASDAQ:PPH) Shares Sold by Comerica Bank - Defense World
VanEck Pharmaceutical ETF (NASDAQ:PPH) Shares Sold by Jane Street Group LLC - Defense World
Trump's Drug Price Order Hits PBMs Hardest: CVS, Cigna, UNH In Focus As Experts Highlight 'Racket,' Pricing DistortionCVS Health (NYSE:CVS), Cigna Group (NYSE:CI) - Benzinga
ETFs to Capitalize on the Novo Nordisk-Septerna Deal - TradingView
Do Wall Street Analysts Like Cencora Stock? - inkl
PPH, Big Pharma Stocks Volatile on Trump Drug Pricing - ETF.com
Stock ETFs Surge on China Tariffs Pact; Bonds, Gold Falter - Yahoo Finance
Biopharma Stocks Rise as Trump Orders Drug Price Cuts - Genetic Engineering and Biotechnology News
ETFs on the Move Post U.S.-China Trade Deal - Nasdaq
Pharma ETFs in Focus on Trump's Drug Price Overhaul - Yahoo Finance
Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now? - NewsBreak: Local News & Alerts
Are Your Health Care ETFs Safe? Trump's New Policies May Trigger Shockwaves Across Pharma Stocks - Benzinga
A Look at Pharma ETFs After Strong Q1 Earnings - Yahoo Finance
Stock Traders Purchase High Volume of VanEck Pharmaceutical ETF Put Options (NASDAQ:PPH) - Defense World
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
Well-Timed Bearish Drug ETF Bet Pays Off on Vaccine Chief News - Bloomberg.com
India proposes zero-for-zero tariff deal on U.S. auto parts, steelreport - Seeking Alpha
Envestnet Asset Management Inc. Has $499,000 Stock Position in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Raymond James Financial Inc. Acquires New Stake in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
VanEck Pharmaceutical ETF (NASDAQ:PPH) Shares Bought by JPMorgan Chase & Co. - Defense World
Where to Invest $10,000 Right Now - Bloomberg.com
VanEck Pharmaceutical ETF Target of Unusually High Options Trading (NASDAQ:PPH) - Defense World
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)? - Nasdaq
ETFs in Focus Post JNJ's Q1 Earnings Beat, Dividend Hike - TradingView
PPH: Will Overcome Tariffs, But Competitor Funds Look Stronger (NASDAQ:PPH) - Seeking Alpha
StockWatch: Trump Tariffs Take Biopharma on a Roller Coaster Ride - Genetic Engineering and Biotechnology News
0.64%
자본화:
|
볼륨(24시간):